Toward a plasma marker for Alzheimer disease
- 19 February 2008
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 70 (8) , 586-587
- https://doi.org/10.1212/01.wnl.0000299905.05595.68
Abstract
The Jacksonville Mayo group compared plasma Aβ42 levels between two cohorts of relatives of patients with …Keywords
This publication has 9 references indexed in Scilit:
- Plasma amyloid β protein is elevated in late-onset Alzheimer disease familiesNeurology, 2008
- Elevated Plasma β-Amyloid Peptide Aβ42 Levels, Incident Dementia, and Mortality in Down SyndromeArchives of Neurology, 2007
- Association of Low Plasma Aβ42/Aβ40 Ratios With Increased Imminent Risk for Mild Cognitive Impairment and Alzheimer DiseaseArchives of Neurology, 2007
- Imaging and CSF Studies in the Preclinical Diagnosis of Alzheimer's DiseaseAnnals of the New York Academy of Sciences, 2007
- Plasma Aβ1–40 and Aβ1–42 and the risk of dementia: a prospective case-cohort studyThe Lancet Neurology, 2006
- Selective Reductions in Plasma A 1-42 in Healthy Elderly Subjects During Longitudinal Follow-Up: A Preliminary ReportAmerican Journal of Geriatric Psychiatry, 2005
- Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic PerspectiveCell, 2005
- Plasma Aβ40 and Aβ42 and Alzheimer’s diseaseNeurology, 2003
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993